BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dastpeyman M, Sharifi R, Amin A, Karas JA, Cuic B, Pan Y, Nicolazzo JA, Turner BJ, Shabanpoor F. Endosomal escape cell-penetrating peptides significantly enhance pharmacological effectiveness and CNS activity of systemically administered antisense oligonucleotides. Int J Pharm 2021;599:120398. [PMID: 33640427 DOI: 10.1016/j.ijpharm.2021.120398] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Winkle M, El-Daly SM, Fabbri M, Calin GA. Noncoding RNA therapeutics - challenges and potential solutions. Nat Rev Drug Discov 2021;20:629-51. [PMID: 34145432 DOI: 10.1038/s41573-021-00219-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 25] [Article Influence: 12.0] [Reference Citation Analysis]
2 Wang J, Chen G, Liu N, Han X, Zhao F, Zhang L, Chen P. Strategies for improving the safety and RNAi efficacy of noncovalent peptide/siRNA nanocomplexes. Adv Colloid Interface Sci 2022;302:102638. [PMID: 35299136 DOI: 10.1016/j.cis.2022.102638] [Reference Citation Analysis]
3 Yu AM, Tu MJ. Deliver the promise: RNAs as a new class of molecular entities for therapy and vaccination. Pharmacol Ther 2021;:107967. [PMID: 34403681 DOI: 10.1016/j.pharmthera.2021.107967] [Cited by in F6Publishing: 1] [Reference Citation Analysis]